Parathyroid hormone stimulation of noncanonical Wnt signaling in bone

Annals of the New York Academy of Sciences

Volumn 1116, Issue , 2007, Pages 354-359

  Bergenstock, Marika K ^a,b   Partridge, Nicola C ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Bone; Osteoblasts; Parathyroid hormone; Wnt signaling; Wnt 4; catenin

Indexed keywords

PARATHYROID HORMONE; WNT4 PROTEIN;

BIOSYNTHESIS; BONE; COMPREHENSION; CONFERENCE PAPER; HORMONE RESPONSE; NONHUMAN; OSTEOPOROSIS;

ANIMALIA;

EID: 37249035650     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.047     Document Type: Conference Paper

References (31)

1. STREWLER, G.J., P.H. STERN, J.W. JACOBS, et al. 1987. Parathyroid hormone-like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J. Clin. Invest. 80: 1803-1807.
2. DEMPSTER, D.W., F. COSMAN, M. PARISIEN, et al. 1993. Anabolic actions of parathyroid hormone on bone. Endocr. Rev. 14: 690-709.
3. FELDMAN, D. 1999. Vitamin D, parathyroid hormone, and calcium: a complex regulatory network. Am. J. Med. 107: 637-639.
4. DOBNIG, H. & R.T. TURNER. 1997. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 138: 4607-4612.
5. ONYIA, J.E., L.M. HELVERING, L. GELBERT, et al. 2005. Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray. J. Cell. Biochem. 95: 403-418.
6. TAM, C.S., J.N. HEERSCHE, T.M. MURRAY & J.A. PARSONS. 1982. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 110: 506-512.
7. SCHILLER, P.C., G. D'IPPOLITO, B.A. ROOS & G.A. HOWARD. 1999. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J. Bone Miner. Res. 14: 1504-1512.
8. COSMAN, F. 2005. The prevention and treatment of osteoporosis: a review. Med. Gen. Med. 7: 73.
9. WESTENDORF, J.J., R.A. KAHLER & T.M. SCHROEDER. 2004. Wnt signaling in osteoblasts and bone diseases. Gene 341: 19-39.
10. DUNCAN, A.W., F.M. RATTIS, L.N. DIMASCIO, et al. 2005. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat. Immunol. 6: 314-322.
11. MILLER, J.R. 2002. The Wnts. Genome Biol. 3:REVIEWS3001.
12. GAVIN, B.J., J.A. MCMAHON & A.P. MCMAHON. 1990. Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development. Genes Dev. 4: 2319-2332.
13. WILLERT, K., J.D. BROWN, E. DANENBERG, et al. 2004. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452.
14. NUSSE, R. 2003. Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development 130: 5297-5305.
15. BEHRENS, J., J.P. VON KRIES, M. KUHL, et al. 1996. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642.
16. YAMANAKA, H., T. MORIGUCHI, N. MASUYAMA, et al. 2002. JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep. 3: 69-75.
17. HABAS, R., I.B. DAWID & X. HE. 2003. Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev. 17: 295-309.
18. CHURCH, V., T. NOHNO, C. LINKER, et al. 2002. Wnt regulation of chondrocyte differentiation. J. Cell Sci. 115: 4809-4818.
19. HARTMANN, C. & C.J. TABIN. 2000. Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 127: 3141-3159.
20. LEE, H.H. & R.R. BEHRINGER. 2007. Conditional expression of Wnt4 during chondrogenesis leads to dwarfism in mice. PLoS ONE. 2: e450.
21. KISPERT, A., S. VAINIO & A.P. MCMAHON. 1998. Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development 125: 4225-4234.
22. VAINIO, S.J. & M.S. UUSITALO. 2000. A road to kidney tubules via the Wnt pathway. Pediatr. Nephrol. 15: 151-156.
23. LYONS, J.P., U.W. MUELLER, H. JI, et al. 2004. Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells. Exp. Cell Res. 298: 369-387.
24. DE BOER, J. R. SIDDAPPA, C. GASPAR, et al. 2004. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34: 818-826.
25. BOLAND, G.M., G. PERKINS, D.J. HALL & R.S. TUAN. 2004. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J. Cell. Biochem. 93: 1210-1230.
26. KULKARNI, N.H., D.L. HALLADAY, R.R. MILES, et al. 2005. Effects of parathyroid hormone on Wnt signaling pathway in bone. J. Cell. Biochem. 95: 1178-1190.
27. QIN, L., P. QIU, L. WANG, et al. 2003. Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J. Biol. Chem. 278: 19723-19731.
28. ONYIA, J.E., L.M. HELVERING, L. GELBERT, et al. 2005. Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray. J. Cell. Biochem. 95: 403.
29. SAWAKAMI, K., A.G. ROBLING, M. AI, et al. 2006. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J. Biol. Chem. 281: 23698-23711.
30. SWARTHOUT, J.T., R.C. D'ALONZO, N. S ELVAMURUGAN & N.J. PARTRIDGE. 2002. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282: 1-17.
31. PARTRIDGE, N.C., X. LI & L. QIN. 2006. Understanding parathyroid hormone action. Ann. N.Y. Acad. Sci. 1068: 187-193.